By utilizing the “most favored countries ‘ drug pricing,” President Donald Trump signed an executive order on Monday to require” Great Pharma” to lower the cost of medicines and medicine in the United States.
Trump stated on Monday,” The concept is simple: Americans will pay whatever the lowest price is paid for a medicine in another developed countries.” ” Some prescription drugs and medical prices may be reduced almost instantly by 50 to 80 to 90 %. Big Pharma will either agree to this theory or use the authority of the federal government to make sure that we are paying the same as other nations.
Trump continued,” Starting nowadays, the United States will no longer support the healthcare of foreign countries, which is what we were doing.” We are subsidizing the care of others in nations where they paid a small fraction of what they did for the same substance, which we pay many, many times more for, and which we will no more tolerate profit and price manipulation from Big Pharma.
The 47th leader, according to The Post Millennial, stated on Monday that Americans now pay 70 % more for prescription drugs than they did in 2000 and that the United States “has the highest medicine costs anywhere in the world by often a factor of five, six, seven, or eight days.”
Trump continued,” Pharmaceuticals firms make more than two-thirds of their income in America, despite the fact that only four percent of the nation’s population lives there.”
Trump’s most recent professional get reverses Obama-era rule MORE
The chairman announced on Monday that the world’s prescribed drug prices may “equalize” in the wake of his “most-favored state” professional order, according to The Post Millennial.
Trump said,” We are going to pay the lowest price there is in the world.” The lowest cost is the one that we will pay, according to the saying.
The White House stated in a , a fact sheet that was provided with the government’s professional attempt on Monday that the administration was directing the U.S. Commerce Department and the Office of the U.S. Trade Representative to “ensure international locations are not engaged in practices that deliberately and badly undercut market prices and cause amount increases in the United States.”
The Trump administration will provide “price targets” to pharmaceutical industry companies to ensure that the United States “gets the best deal” when it comes to pharmaceutical companies. Additionally, Robert F. Kennedy Jr., the secretary of health and human services, is under the command of the executive order to create a system that allows Americans to buy drugs directly from manufacturers that offer” Most-Favored-Nation” prices.
If drug manufacturers don’t offer” Most-Favored-Nation” pricing to American patients, Kennedy will be asked to” ( 1 ) propose rules that would require most-favored-nation pricing, ( 2 ) take other aggressive measures to significantly lower the cost of prescription drugs to the American consumer and put an end to anticompetitive practices.”
